Both hypertension and cognitive decline are common nificant sensory impairment or interrupted testing. No significant differences in cognitive decline were found in old age. We sought to examine the effects of blood pressure (BP) on rates of cognitive decline in a longibetween those who had started medication (n = 163) and those remaining untreated (n = 224). Mean MMSE score tudinal study of community-resident healthy old people. 
Introduction
health due to cardiovascular disease and cancer will Recently many investigators have examined the tend to have low BPs and score worse on tests of relationship between hypertension and cognitive cognitive function. Moreover, cognitive impairment impairment, [1] [2] [3] [4] two common conditions in the elditself may not be so clinically relevant as the rate of erly. 5, 6 The prevalence of casual systolic hypertencognitive decline. 13 Differences over time in cognision (systolic blood pressure (SBP) Ͼ159 mm Hg on tive measures are generally less reliable than single a single reading) in the USA increases from 19% in scores 14 and their relationship to the first observed men aged 60 years to 41% in men aged 80 years. 7 score is statistically complex. 13 The prevalence of casual systolic hypertension
We addressed some of these methodological increases for women also, from 27% at 60 years to issues in our previous cross-sectional study 50% at 80 years. 7 Hypertension accelerates cognitive reports. 12, 15 We quantified the effects of education, decline not only in vascular dementia (VaD), 8 but pre-morbid IQ, social class and other factors on cogalso in Alzheimer's disease. 9 These cognitive losses nitive function in a sample of healthy old people. 15 are thought to occur due to cerebrovascular disease We found an association between elevated BP and and may relate to both insulin resistant states 10 and cognitive impairment 12 and predicted that rate of altered blood rheology. 11 The effect of high BP on decline would be affected by pre-morbid IQ. 15 We cognitive decline in healthy people is less clear. now present longitudinal data from a 4-year followStudies suggest that elevated SBP is associated with up of the original healthy sample which relate cogfaster decline, 3,4 but inferences drawn from longinitive decline to BP. tudinal studies need to be viewed in the context of methodological limitations, particularly potential
Subjects and methods
confounding from medication and disease. 2, 12 Furthermore, confounding due to correlation of hyper-
The initial sample of healthy old people was tension with other risk factors for cognitive impairdescribed previously. 12,15 Subjects aged 70 years and ment, eg, low socio-economic status, needs to be over were identified from age-sex registers of 67 genconsidered. Confounding may also obscure a posieral practitioners in Edinburgh. 0.02) though the effect sizes were typically small. Starting medication had no effect on MMSE score (P Follow-up was planned after 4 years, following consideration of change in MMSE score per year = 0.59). inferred from the cross-sectional data 12 and the expected attrition rate. Casenotes of the 603 subjects Repeated measures analysis of variance of MMSE were searched for at the original general practices. score When these could not be located, the subject's records was traced at the local Primary Care Division
We first modelled the effects of baseline characteristics on change in MMSE score by repeated measwhere the outcome was: (i) transfer to another local general practitioner; (ii) transfer to a general pracures analysis of variance. This allows significant effects to be detected before complicating analysis titioner outwith Edinburgh; or (iii) death. If a subject had died in Scotland, their death certificate was by using actual change scores 13, 14 and is robust to deviations from parametric assumptions about located at centrally held records for Scotland at Register House, Edinburgh.
19 Subjects who were still MMSE scores whilst homogeneity of variance between groups is maintained. Setting baseline and living in Edinburgh were invited to participate in retesting. Those who agreed were again visited by a follow-up BPs as covariates in the model showed an effect of SBP over time (F = 5.67, P = 0.018) and a research nurse at home and the MMSE and NART readministered. BP was measured as before and lesser effect of diastolic BP (DBP) over time (F = 4.94, P = 0.027). There were no significant interdirect enquiry made about health and medications. All available casenotes of subjects were scrutinised action effects of either gender or SOC by time on MMSE score. by a research nurse (SI, SC) and reviewed by a physician (JMS). Subjects were categorized as having newly diagnosed disease if either they reported it or Regression modelling of change in MMSE scores it was documented in their casenotes. 20 Similarly, properties of residuals were checked in mulof −5 to +13 (median 0 points, inter-quartile range 2 tiple linear regression modelling and eigenvalues calculated to investigate potential colinearity. up for other reasons including 13 subjects whose Table 2 . Baseof NART-IQ was marginally non-significant (P = line variables were then entered into a multiple lin-0.0501). ear regression analysis. This fulfilled residuals criIn consideration of the potential MMSE ceiling teria, but identified eight cases (2.1%) as outliers effect, a further model was produced with only cases beyond 3 standard deviations from the mean. Univawhere initial MMSE score fell below median (n = riate effects of variables including and excluding 172). This confirmed the MMSE effect (␤ = 0.232, P outliers from analysis are shown in Table 3 and indi-= 0.0017) together with those of SBP (␤ = 0.241, P = cate how influential these cases are on regression 0.0011) and age (␤ = 0.174, P = 0.018). MMSE score coefficients. In view of the major influence of outand NART-IQ exhibited some collinearity with one liers on regression coefficients. Outliers were coneigenvalue explaining 60% and 45% of their sidered in a separate analysis (see below) and all respective variances. baseline variables were entered into a stepwise regression analysis for the remaining 379 subjects.
Characteristics of the group with 'catastrophic' Significant effects were found for age, MMSE, SBP, cognitive decline NART-IQ and period between testing (F = 22.92, P Ͻ 0.001, adjusted r 2 = 0.226, Table 4 ). Excluding initial
We were able to ascertain a definite outcome after 4 years for 513 subjects (429 revisited, 69 dead and 15 MMSE score from analysis significant effects remained with SBP, follow-up period and years of with intercurrent illness). Of these, 21 subjects either had documented dementia or were outliers education with model (adjusted r 2 = 0.043), whilst excluding NART-IQ produced a superior model and not considered in the above analysis with falls in MMSE score greater than 6 points (more than 3 (adjusted r 2 = 0.209) with MMSE score, age, SBP and period all significant. standard deviations). We performed logistic regression analysis for these 21 cases and 492 controls. The optimal model consisted of age (OR 1.13, 95% CI 1.02-1.26 per year, P = 0.018) and initial MMSE score (OR 0.70, 95% CI 0.57-0.87 per point, P = 0.001) only. Baseline BP had no effect.
Discussion
In considering the rate of cognitive decline in our sample of initially healthy old people as measured by the MMSE, the effects of the initial MMSE score need to be controlled for. 13 It appears that both ceiling effects and regression to the mean phenomena explain a considerable proportion of the effect of initial MMSE score on change in score. In view of this, the degree of decline itself becomes less important for interpreting the results than the determinants of change. In our sample, baseline variables predicted approximately one-quarter of the variance (Table 4) suggests that three baseline variables exert significant effects: (1) older people exhibit a faster decline; (2) those shows catastrophic and normal cognitive decline as two separate entities consistent with the number of with higher NART-IQ scores are relatively protected; and (3) those with high SBPs are at greater risk of outliers we found. However, we only identified a few outliers and these lines may represent two ends cognitive decline. These findings are consistent with those inferred from our cross-sectional data.
12,15 of a broad spectrum. For the bulk of the population, we can infer that a decrease in mean population SBP Reassuringly, we were also able to detect an independent significant correlation between length of of 4 mm Hg would reduce the rate of cognitive decline as measured by the MMSE by 10%. A popufollow-up period and MMSE decline.
Higher baseline systolic pressure was associated lation strategy which reduced mean BP by a small amount might be thought attractive, but its prewith a greater decline in MMSE score in those subjects who remained medication-free over the 4-year dicted impact assumes that all elderly people are at risk of hypertension-associated cognitive decline. follow-up, but its effect was marginally non-significant in subjects who were both medication-free and
We and others have previously argued that distinct 'at-risk' groups are likely to exist within the popudisease-free according to self-report and general practice casenotes. This suggests that any deleterilation with brains particularly vulnerable to hypertensive insult. 2 These putative 'at-risk' groups may ous influence of raised BP cannot be attributed solely to antihypertensive medication. Indeed, indeed contain members with other distinct dementia-inducing neuropathologies such as Alzhexcluding subjects diagnosed by their family doctors as having hypertension, baseline SBP remained an eimer's disease. Subjects with limited cerebral reserve may be especially vulnerable. Our longitudiimportant predictor of cognitive decline. The model for subjects with incident disease, excluding lone nal data show that not only do older people with lower pre-morbid IQs score worse on the MMSE, but hypertension, explained far less variance than either that of the drug-free or disease-and drug-free their rate of decline is faster also. Our findings are generally consistent with the few groups. However, SBP was a significant predictor in this model. Hence, part of the explanation of how a previous reports which concentrate on longitudinal rather than cross-sectional data. Cognitive function high baseline SBP worsens cognitive decline is by secondary disease (eg, stroke, cardiac failure).
of elderly Japanese-Americans resident in Hawaii correlates inversely with midlife systolic, but not The effect sizes we detected, although highly significant, were relatively small. Most healthy old diastolic, BP. 4 Prevalent cerebrovascular and cardiovascular disease reduced the strength of this people will exhibit a minimal decline in cognitive function over 4 years as measured by the MMSE.
relationship. Somewhat weaker associations between previous BP and current cognitive function Most people with below average MMSE scores will perform better on retesting due to the phenomenon were found in the Framingham study, 3 with age a more significant factor in determining mental abiliof regression to the mean. A few subjects with lower MMSE scores will fail to regress to the mean since ties. Other phenomena, such as MRI white matter hyperintensities 21 and increased blood viscosity, 22 they are already on the path of catastrophic decline. Such catastrophic cognitive declines leading to which correlate both with age and BP may relate more strongly to cognitive decline. Moreover, twin dementia are likely to occur in more advanced age. It is unclear whether the deleterious effect of studies suggest that systolic hypertension may be part of a cluster of characteristics related to underlyincreased age on the rate of decline in the majority of people is due to the inclusion of a few subjects ing genotypes predisposed to accelerated cognitive decline. 23 already dementing, but whose decline has only recently started. The model proposed in Figure 1 Our selection of an initially healthy sample con-
